Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
Category
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Diagnosing Dementia-Related Psychosis: Using Tools and Communicating With Patients and Caregivers
What diagnostic criteria and assessment tools would you use for dementia-related psychosis? What strategies may help when discussing psychosis with patients’ family members? Dr Ballard considers these topics in this brief CME activity.
Category
  • Delivery of Care
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
How to Assess Tardive Dyskinesia Symptom Improvement With Measurement-Based Care
Measurement-based care has been found to be effective in patients with psychiatric conditions. Learn how to employ MBC for patients with tardive dyskinesia.
Category
  • Delivery of Care
  • Movement Disorders
  • Neurology
  • Tardive Dyskinesia
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Collaborating With Patients to Make Treatment Decisions Based on Benefits and Risks of Medications Associated With Tardive Dyskinesia
Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.
Category
  • Antipsychotics
  • Movement Disorders
  • Neurology
  • Patient/Physician Communication
  • Tardive Dyskinesia
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments
What are the cardinal features of Parkinson disease? What other motor and nonmotor symptoms do patients experience? Review diagnosis and assessment tools.
Category
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease
Which medications can improve the motor and nonmotor symptoms of Parkinson disease? Dr Isaacson offers strategies to address multiple challenges.
Category
  • Movement Disorders
  • Neurology
  • Parkinson Disease
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
FDA-Approved Medications to Treat Tardive Dyskinesia
Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Learn more from Dr. Joseph McEvoy.
Category
  • Antipsychotics
  • Functional Impairment
  • Movement Disorders
  • Neurology
  • Side Effects
  • Tardive Dyskinesia
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Pharmacology and Evidence-Based Strategies for Current and Emerging Treatments for OFF Periods in Parkinson Disease
After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy “wears off.” How can you increase their ON time? In this CME activity, follow along as 2 experts review evidence on treatment.
Category
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • Side Effects
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder
In this CME activity, listen to a panel of MDD experts discuss best practices and novel antidepressants at the 2019 ASCP Annual Meeting.
Category
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication
Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. Here, learn strategies for disclosing the diagnosis.
Category
  • Alzheimer Disease
  • Dementia
  • Neurology
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation

Pages